Metraipolis › archive › dc_32bdffb10b11

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a… — Europe PMC PMID:27732588

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/27732588
DOI
10.1371/journal.pntd.0005030
License (as archived)
solo-consultazione
Archived
2026-10-08T03:01:42.079Z
SHA-256 of the archived text
3fcd0a9a0938ebebd119e2a8f6fc9b9f8037da9048c72d985ffa0de756494f24
Stable URL of this page
https://metraipolis.com/documento/dc_32bdffb10b11

How to cite

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a… — Europe PMC PMID:27732588 — Europe PMC (en), https://europepmc.org/article/MED/27732588 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_32bdffb10b11 (Metraipolis archive dc_32bdffb10b11, sha256 3fcd0a9a0938ebebd119e2a8f6fc9b9f8037da9048c72d985ffa0de756494f24)
BibTeX
@misc{dc32bdffb10b11,
  title = {Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a… — Europe PMC PMID:27732588},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/27732588},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_32bdffb10b11; sha256 3fcd0a9a0938ebebd119e2a8f6fc9b9f8037da9048c72d985ffa0de756494f24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/27732588. Agents can read the archived copy with the MCP tool read_document.